RxDoctor Payments Data

Joshua Osbun, MD

Neurological Surgery · Saint Louis, MONPI 1316139793

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 37.2% of the total. Reporting peaked in 2021 at $28,850 and has fallen 98.7% since, to $375 in 2025. Among neurological surgery clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$97,906in general payments, 2019–2025

Across 157 payments — averaging $623.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$36K
  • Stryker$33K
  • Microvention, Inc.$12K
  • Terumo Medical Corporation$9K
  • Penumbra, Inc.$7K
  • Route 92 Medical, Inc.$352
  • plus $141 from 4 others
$321,306in research payments, 2019–2025

Across 59 payments — averaging $5445.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Microvention, Inc.$159K
  • Medtronic$62K
  • Medical Device Business Services, Inc.$54K
  • Route 92 Medical, Inc.$24K
  • Stryker$22K

What the payments were for

  • Consulting fees$54,71056%
  • Speaking & faculty fees$23,65024%
  • Grants$4690%
  • Travel & lodging$14,64415%
  • Food & beverage$4,4335%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$97,906 in reported general payments places this provider in the 90th percentile of 172 neurological surgery providers in Missouri.

See all neurological surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$194,259
Medicare patients
288
Services billed
779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor14$6,365
Levetiracetam38$1,083
ClopidogrelClopidogrel Bisulfate71$421
Gabapentin28$347
Carbamazepine13$244
Mupirocin18$137
Oxycodone Hcl24$128
Rosuvastatin Calcium16$120
Atorvastatin Calcium19$105
Famotidine13$20
Diazepam13$14

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →